JPRN-UMIN000052957尚未招募Unknown
Registry of Psoriasis Health Outcomes: A Longitudinal Real-world Collaboration (RePhlect) - A real-world, prospective, observational study of the comparative effectiveness of deucravacitinib in adults with plaque psoriasis in Japan - RePhlect Japan
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet any of the following criteria will be excluded from the study: - Patients currently participating in or planning to participate in an interventional clinical trial - Patients enrolled in DEUC Post Marketing Surveillance (PMS; ClinicalTrial.gov ID: NCT05633264) - Previous treatment experience with the treatment of interest (e.g. patients who have history of APR will not be eligible to be enrolled in APR arm of the study and similar for DEUC)
研究者
相似试验
招募中
不适用
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)Plaque PsoriasisNCT06382987Bristol-Myers Squibb600
已完成
4 期
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic TherapyPsoriasisNCT04908475AbbVie352
已完成
不适用
Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in TaiwanPsoriasisNCT04818385AbbVie240
已完成
不适用
A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail PsoriasisNail PsoriasisNCT03946826xjpfW20
已完成
不适用
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric PsoriasisPsoriasisNCT01100034Pfizer72